Clinical Markers of Panic and Generalized Anxiety Disorder
NCT ID: NCT06071819
Last Updated: 2023-10-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
290 participants
OBSERVATIONAL
2022-08-01
2022-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* which socio-demographic/clinical markers are associated to GAD or PD diagnosis?
* which factors are associated with a longer duration of untreated illness (DUI) in GAD and in PD? Participants will signed a written informed consent and socio-demographic/clinical variables will be retrospectively collected. Researchers will compare GAD and PD groups in terms of socio-demographic and clinical features, including DUI, to better characterize the two disorders and to investigate factors associated to a longer DUI.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pain Processing in Anxiety and Depression
NCT00560196
Psychotherapy Outcome and Self-selection Effects in Panic Disorder
NCT01606592
Neurobiological Mechanisms in Panic Disorder
NCT00103987
Effectiveness of Cognitive Behavioral Therapy With Panic Control Treatment for Adolescents With Panic Disorder
NCT00705380
Efficacy and Mechanisms of Psychosocial Treatments for Panic Disorder
NCT04366011
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Generalized Anxiety Disorder (GAD)
Patients affected by GAD
Structured Clinical Interview for DSM-5
A structured interview will be administered to confirm the diagnosis reported in clinical charts
Panic Disorder (PD)
Patients affected by Panic Disorder
Structured Clinical Interview for DSM-5
A structured interview will be administered to confirm the diagnosis reported in clinical charts
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Structured Clinical Interview for DSM-5
A structured interview will be administered to confirm the diagnosis reported in clinical charts
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ability and willing to give informed consent;
* fluency in Italian language;
* diagnosis of GAD or PD according to the criteria of the Diagnostic and Statistical Manual of Mental Disorder, 5th edition.
Exclusion Criteria
* lack of clinical and socio-demographic information;
* patients treated for less than three months in the outpatient clinics for the impossibility of a comprehensive collection of clinical variables.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Milan
OTHER
University of Milano Bicocca
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alice Caldiroli
Psychiatrist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alice Caldiroli, Doctor
Role: PRINCIPAL_INVESTIGATOR
University of Milano Bicocca - Fondazione IRCCS San Gerardo dei Tintori
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Milano Bicocca - Fondazione IRCCS San Gerardo dei Tintori
Monza, MB, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GAD-PD-3955
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.